{{medical}}
'''ZMapp'''是一种用来产生对[[埃博拉病毒|埃博拉病毒]]免疫反应的药物，该药物是三个[[人源化|人源化]][[抗体|抗体]]的血清混合物。<ref name=ZMappInfoSheet>{{cite web |url=http://www.mappbio.com/zmapinfo.pdf |title=ZMapp Information Sheet |publisher=Mapp Biopharmaceutical |deadurl=yes |archiveurl=https://web.archive.org/web/20140812212046/http://www.mappbio.com/zmapinfo.pdf |archivedate=2014-08-12 |accessdate=2014-08-10 }}</ref><ref>{{cite journal|url=http://www.pnas.org/content/108/51/20690.abstract?sid=a570a830-ca93-4cd2-aa8c-47de89fe0327|title=Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant|year=2011|journal=PNAS|doi=10.1073/pnas.1108360108|authors=Larry Zeitlin, James Pettitt, Corinne Scully, Natasha Bohorova, Do Kim, Michael Pauly, Andrew Hiatt, Long Ngo, Herta Steinkellner, Kevin J. Whaley, and Gene G. Olinger|access-date=2014-08-10|archive-date=2021-04-16|archive-url=https://web.archive.org/web/20210416203357/https://www.pnas.org/content/108/51/20690.abstract?sid=a570a830-ca93-4cd2-aa8c-47de89fe0327|dead-url=no}}</ref><ref name=Zeitlin2012>{{cite journal|url=http://www.pnas.org/content/109/44/18030.full?sid=ec334f96-1b52-465b-aad9-25b716b3f669|title=Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques|year=2012|journal=PNAS|doi=10.1073/pnas.1213709109|authors=Gene Garrard Olinger Jr, James Pettitt, Do Kim, Cara Working, Ognian Bohorov, Barry Bratcher, Ernie Hiatt, Steven D. Hume, Ashley K. Johnson, Josh Morton, Michael Pauly, Kevin J. Whaley, Calli M. Lear, Julia E. Biggins, Corinne Scully, Lisa Hensley, and Larry Zeitlin|access-date=2014-08-10|archive-date=2021-04-23|archive-url=https://web.archive.org/web/20210423003247/https://www.pnas.org/content/109/44/18030.full?sid=ec334f96-1b52-465b-aad9-25b716b3f669|dead-url=no}}</ref>  2014年7月31日，该药物在病人上开始了第一次试验。两位感染了埃博拉病毒的美国人接受了治疗。一位患者在施药后都有了好转的迹象、另一位因有併發症而宣告死亡。<ref name=CNN4Aug14>{{cite web|title=Experimental drug likely saved Ebola patients|authors=Dr. Sanjay Gupta and Danielle Dellorto|date=August 4, 2014|publisher=CNN|url=http://www.cnn.com/2014/08/04/health/experimental-ebola-serum/index.html|access-date=2014-08-10|archive-date=2022-03-15|archive-url=https://web.archive.org/web/20220315232923/https://www.cnn.com/2014/08/04/health/experimental-ebola-serum/index.html|dead-url=no}}</ref><ref name="#1">"[http://www.latimes.com/science/sciencenow/la-sci-sn-ebola-serum-20140804-story.html Mystery Ebola virus serum manufactured by San Diego firm] {{Wayback|url=http://www.latimes.com/science/sciencenow/la-sci-sn-ebola-serum-20140804-story.html |date=20210828081558 }}". Los Angeles Times. August 4, 2014.</ref> 2014年8月22日院方召開記者會<ref>"[http://www.bastillepost.com/hongkong/%E5%A4%A7%E8%A6%96%E9%87%8E/%E4%BC%8A%E6%B3%A2%E6%8B%89%E5%89%8B%E6%98%9F%E6%88%96%E9%9D%A2%E4%B8%96-%E7%BE%8E%E6%9F%93%E7%97%85%E9%86%AB%E7%94%9F%E5%BA%B7%E5%BE%A9%E5%87%BA%E9%99%A2?r=w 伊波拉剋星或面世美染病醫生康復出院] {{Wayback|url=http://www.bastillepost.com/hongkong/%E5%A4%A7%E8%A6%96%E9%87%8E/%E4%BC%8A%E6%B3%A2%E6%8B%89%E5%89%8B%E6%98%9F%E6%88%96%E9%9D%A2%E4%B8%96-%E7%BE%8E%E6%9F%93%E7%97%85%E9%86%AB%E7%94%9F%E5%BA%B7%E5%BE%A9%E5%87%BA%E9%99%A2?r=w |date=20140826115508 }}" 巴士的報 2014年08月22日</ref>表示1人已完全康復，不過院方指他們不清楚Zmapp是否有效，也不確定患者是因藥物康復或是自行康復，也不清楚2位病患接受的實驗性治療，是否會出現長期的副作用，但感染伊波拉康復的病人，不會再復發也不具傳染性，並指出營養比較好的病患通常有比較高的存活率。另一名在賴比瑞亞感染伊波拉病毒的75歲西班牙神父也使用ZMapp，但也宣告不治。

ZMapp是由Mapp生物制药公司开发的，<ref name="#1"/>是Mapp生物制药（[[圣迭戈_(加利福尼亚州)|圣迭戈]]）、LeafBio（Mapp生物制药的商业部门）、<ref>{{cite web|url=http://www.leafbio.com/|title=LeafBio|accessdate=August 12, 2014|archive-url=https://web.archive.org/web/20141008183506/http://www.leafbio.com/|archive-date=2014-10-08|dead-url=yes}}</ref>Defyrus公司（[[多伦多|多伦多]]）、美国政府以及[[加拿大公共卫生署|加拿大公共卫生署]]联合的成果。<ref name=ZMappInfoSheet />该抗体出自十几年前由美国军方资助的研究项目。<ref name=BW4Aug14>{{cite web|url=http://www.businessweek.com/news/2014-08-04/ebola-drug-made-from-tobacco-plant-saves-u-dot-s-dot-aid-workers|title=Ebola Drug Made From Tobacco Plant Saves U.S. Aid Workers|date=August 4, 2014|publisher=BusinessWeek|authors=Robert Langreth, Caroline Chen, James Nash and John Lauerman|access-date=2014-08-10|archive-date=2015-01-24|archive-url=https://web.archive.org/web/20150124090043/http://www.businessweek.com/news/2014-08-04/ebola-drug-made-from-tobacco-plant-saves-u-dot-s-dot-aid-workers|dead-url=no}}</ref> 美国[[国防威胁降低局|国防威胁降低局]]已经宣布，基于“良好的前景”，将追加对Mapp生物制药的投资。<ref>{{cite web|date=August 4, 2014|url=http://www.newsweek.com/us-sitting-promising-ebola-vaccines-262870|title=The U.S. Is Sitting on Promising Ebola Vaccines|publisher=NewsWeek|access-date=2014-08-10|archive-date=2022-03-15|archive-url=https://web.archive.org/web/20220315204331/https://www.newsweek.com/us-sitting-promising-ebola-vaccines-262870|dead-url=no}}</ref>

==参考文献==
{{reflist}}

[[Category:免疫学|Category:免疫学]]
[[Category:单克隆抗体类|Category:单克隆抗体类]]
[[Category:治疗用抗体|Category:治疗用抗体]]
[[Category:药物|Category:药物]]
[[Category:生物技术产品|Category:生物技术产品]]
[[Category:伊波拉出血熱|Category:伊波拉出血熱]]
[[Category:分子生物学小作品|Category:分子生物学小作品]]